Selective,non-steroidalfarnesoidXreceptor(FXR)agonist(EC50=15nM).Displaysnoactivityatothernuclearreceptorsatconcentrationsupto1μM.Improveshyperglycaemiaandhyperlipidemiaindiabeticdb/dbmice.Showntosuppressautophagyinnutrient-deprivedmousehepatocytes.
SoldforresearchpurposesunderagreementfromGlaxoSmithKline
M.Wt | 542.84 |
Formula | C28H22Cl3NO4 |
Storage | Desiccateat+4°C |
Purity | ≥97%(HPLC) |
CASNumber | 278779-30-9 |
PubChemID | 9893571 |
InChIKey | BYTNEISLBIENSA-MDZDMXLPSA-N |
Smiles | CC(C)C1=C(COC2=CC(Cl)=C(C=CC3=CC=CC(=C3)C(O)=O)C=C2)C(=NO1)C1=C(Cl)C=CC=C1Cl |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 54.3 | 100 | |
ethanol | 5.43 | 10 |
Thefollowingdataisbasedontheproductmolecularweight542.84.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 1.84mL | 9.21mL | 18.42mL |
5mM | 0.37mL | 1.84mL | 3.68mL |
10mM | 0.18mL | 0.92mL | 1.84mL |
50mM | 0.04mL | 0.18mL | 0.37mL |